AzTrials
AzTrials

Autism Spectrum DisorderNCT04820647

KF STRIDE to Improve Job Interview Skills

A study testing KF-STRIDE in people with Autism Spectrum Disorder, run by Kessler Foundation at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU). Read more about this study

Who is it for?
Ages 14 to 26 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
KF-STRIDE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
29 Mar 2021to 12 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 26 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • adolescents with Autism Spectrum Disorder
  • Live in the United States of America
  • Ages of 14-26
  • Speak English fluently and at a 4th grade reading level

Who cannot join

  • History of stroke, Traumatic Brain Injury, or neurological injury or disease in the past (like brain tumor or epilepsy).
  • History of significant psychiatric illness
  • Uncontrolled seizures or other unstable medical complications.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Kessler Foundation

    East Hanover, New Jersey, 07936

Other trials in United States

About this study

Official title: A Strength-Based Intervention to Improve Job Interview Skills in Young Adults

The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU).

Read the detailed description

This study will evaluate the acceptability and effectiveness of a strength-based intervention (Kessler Foundation Strength Identification and Expression; KF-STRIDE) that can enhance job interview skills and employment. Despite possessing employable talents, the core social deficits of transition age youth with autism spectrum disorder (TAY-ASD) make it difficult for this group to articulate their individual strengths. This inability to identify and express one's strengths to a potential employer can negatively affect interview performance and lead to difficulty with job obtainment. Thus, the current proposal will examine the effectiveness (Aim 1), acceptability, usability, and feasibility (Aim 2) of a novel strength-based intervention, KF-STRIDE, which is designed to enhance the ability of TAY-ASD to identify personal strengths and effectively discuss them. The goals of the current study are to evaluate the preliminary effectiveness and feasibility of KF-STRIDE in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU). The study will be performed at two private therapeutic schools. Compared to a SAU group, we hypothesize that the KF-STRIDE group will: a) improve the ability to identify strengths (Hypothesis 1), b) improve the ability to express strengths (Hypothesis 2), c) improve other job interview skills (Hypothesis 3) and finally c) improve ability to obtain employment 6-months following the intervention (Hypothesis 4). In this way, the current study is in line with the NIMH's experimental therapeutics model, as we will examine whether the intervention improves employment, as well as identify potential mechanistic targets that could affect outcome. In Aim 2, we will also monitor fidelity, acceptability, usability, and feasibility of the strength-based intervention. The long-term goal of the current research is to collect pilot data that will lead to fully-powered effectiveness and implementation evaluations of KF-STRIDE in other community settings.

Being tested
KF-STRIDE
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KF-STRIDEBehavioural

    KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview

Study groups in NCT04820647
Study groupRoleWhat they receive
Kessler Foundation STRength IDentification and Expression (KF-STRIDE)ExperimentalNot described
Receives: Behavioral: KF-STRIDE
Services as UsualNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mock Job Interview

    Blinded reviewers using a standardized scoring measure will rate the video recorded mock job interviews.

    Measured: Week 8

  2. employment status (yes=1, no=0)

    We will examine whether the person became employed or other changes to their employment status.

    Measured: 6 months post intervention

  3. time-to-reach-employment (assessed as weeks since intervention completion).

    We will examine how long it took for the person to obtain employment.

    Measured: 6 months post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2021
  2. Study start29 Mar 2021
  3. Primary completion12 Jan 2024
  4. Study completion12 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04820647
Sponsor's protocol ID
E-1139-21
Status last verified
Mar 2024
First submitted
25 Mar 2021
Last updated
20 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing KF-STRIDE in people with Autism Spectrum Disorder, run by Kessler Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mock Job Interview (time frame: Week 8). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
KF STRIDE to Improve Job Interview Skills | AzTrials